The Acute Myeloid Leukemia Channel is supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BSH 2019 | Defining the role of NFIC in AML
Namrata Rastogi
• 2 Apr 2019
Namrata Rastogi, PhD, Cardiff University, Cardiff, UK, discusses her research into nuclear factor I/C (NFIC), a transcription factor, and it’s role in acute myeloid leukemia (AML). This interview took place at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK.
